These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19664323)

  • 21. BAMHI DNA fragment H-polymorphism of Epstein-Barr virus is associated with the mutations present in an 89 BP sequence localized in EBNA2 gene.
    Sheng W; Bouguermouh A; Bouzid M; Djennaoui D; Ooka T
    Virus Genes; 2004 Aug; 29(1):99-108. PubMed ID: 15215688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of an Epstein-Barr-virus receptor and Epstein-Barr-virus-dependent transformation of human nasopharyngeal epithelial cells.
    Shao X; He Z; Chen Z; Yao K
    Int J Cancer; 1997 May; 71(5):750-5. PubMed ID: 9180141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EBV reactivation as a target of luteolin to repress NPC tumorigenesis.
    Wu CC; Fang CY; Hsu HY; Chuang HY; Cheng YJ; Chen YJ; Chou SP; Huang SY; Lin SF; Chang Y; Tsai CH; Chen JY
    Oncotarget; 2016 Apr; 7(14):18999-9017. PubMed ID: 26967558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymyositis/dermatomyositis and nasopharyngeal carcinoma: the Epstein-Barr virus connection?
    Chen DY; Chen YM; Lan JL; Chen HH; Hsieh CW; Wey SJ; Lu JJ
    J Clin Virol; 2010 Dec; 49(4):290-5. PubMed ID: 20934910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma (NPC).
    Liu MT; Yeh CY
    Radiat Med; 1998; 16(2):113-7. PubMed ID: 9650898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virus-associated lymphomas, leukaemias and immunodeficiencies in Africa.
    de-Thé G
    IARC Sci Publ; 1984; (63):727-44. PubMed ID: 6100286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma.
    Hui KF; Ho DN; Tsang CM; Middeldorp JM; Tsao GS; Chiang AK
    Int J Cancer; 2012 Oct; 131(8):1930-40. PubMed ID: 22261816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Epstein-Barr virus infection on global gene expression in nasopharyngeal carcinoma.
    Lee YC; Hwang YC; Chen KC; Lin YS; Huang DY; Huang TW; Kao CY; Wu HC; Lin CT; Huang CY
    Funct Integr Genomics; 2007 Jan; 7(1):79-93. PubMed ID: 16988809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between PPP1R15A gene polymorphism (rs611251) and Epstein-Barr virus-associated tumors.
    Song Y; Liu S; Zhao Z; Zhang Y; Yang Y; Luo B
    Acta Virol; 2017; 61(4):445-452. PubMed ID: 29186961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The discovery of Burkitt's lymphoma.
    Burkitt DP
    Cancer; 1983 May; 51(10):1777-86. PubMed ID: 6299496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
    Hui KF; Tam KP; Chiang AKS
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29160853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High risk Epstein-Barr virus variants characterized by distinct polymorphisms in the EBER locus are strongly associated with nasopharyngeal carcinoma.
    Hui KF; Chan TF; Yang W; Shen JJ; Lam KP; Kwok H; Sham PC; Tsao SW; Kwong DL; Lung ML; Chiang AKS
    Int J Cancer; 2019 Jun; 144(12):3031-3042. PubMed ID: 30536939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM
    J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burkitt's lymphoma - a human tumor model system for immunological studies.
    Gunvén P
    Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of Epstein-Barr virus DNA load in nasopharyngeal brushing samples in the diagnosis of nasopharyngeal carcinoma in southern China.
    Zheng XH; Lu LX; Li XZ; Jia WH
    Cancer Sci; 2015 Sep; 106(9):1196-201. PubMed ID: 26082292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
    Gunvén P; Klein G; Henle G; Henle W; Clifford P
    Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.